Clinical trial
Non-Response to Naltrexone (NTX): Next Steps in Managing Alcoholism
NCT00115037 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Non-Response to Naltrexone (NTX): Next Steps in Managing Alcoholism
- Lead sponsor
- University of Pennsylvania
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 30, 2003
- Completion date
- July 31, 2008
- Enrollment
- 302 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.